Amarantus BioScience Holdings, Inc. is a biopharmaceutical company, which engages in developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. It focuses on acquiring product and technology rights, raising capital, and performing research and development. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Amarantus BioScience Holdings Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Amarantus BioScience Holdings Inc market cap is $400.00.
What is the 52-week high for Amarantus BioScience Holdings Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Amarantus BioScience Holdings Inc 52 week high is $0.0401 as of September 06, 2025.
What is the 52-week low for Amarantus BioScience Holdings Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Amarantus BioScience Holdings Inc 52 week low is $0.00 as of September 06, 2025.
What is the 50-day moving average of Amarantus BioScience Holdings Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Amarantus BioScience Holdings Inc 50-day moving average is $0.00.